Literature DB >> 5799031

Exogenous interferon and inducers of interferon in the treatment Balb-c mice inoculated with RC19 tumour cells.

I Gresser, C Bourali.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5799031     DOI: 10.1038/223844a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

Review 1.  Immunomodulatory cytokines as therapeutic agents for melanoma.

Authors:  Courtney Nicholas; Gregory B Lesinski
Journal:  Immunotherapy       Date:  2011-05       Impact factor: 4.196

Review 2.  Signal pathways of melanoma and targeted therapy.

Authors:  Weinan Guo; Huina Wang; Chunying Li
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

3.  Inducers of interferon inhibit the mitotic response of liver cells to partial hepatectomy.

Authors:  R I Jahiel; D Taylor; N Rainford; S E Hirschberg; R Kroman
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

4.  The role of interferon in the protective effect of a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice.

Authors:  E De Clercq; M R Nuwer; T C Merigan
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808

5.  Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparations.

Authors:  I Gresser; D Brouty-Boyé; M T Thomas; A Macieira-Coelho
Journal:  Proc Natl Acad Sci U S A       Date:  1970-08       Impact factor: 11.205

6.  Prolongation of survival of mice bearing the Eb and ESb lymphoma by treatment with interferon inducers alone or in combination with Corynebacterium parvum.

Authors:  E Storch; H Kirchner; V Schirrmacher
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

7.  Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling.

Authors:  Jennifer R Bourn; Sasha J Ruiz-Torres; Brian G Hunt; Nancy M Benight; Susan E Waltz
Journal:  Cancer Lett       Date:  2021-01-27       Impact factor: 8.679

Review 8.  Cancer immunotherapy and nanomedicine.

Authors:  Wei-Yun Sheng; Leaf Huang
Journal:  Pharm Res       Date:  2010-09-04       Impact factor: 4.580

Review 9.  Targeting the tumor microenvironment to enhance antitumor immune responses.

Authors:  Kevin Van der Jeught; Lukasz Bialkowski; Lidia Daszkiewicz; Katrijn Broos; Cleo Goyvaerts; Dries Renmans; Sandra Van Lint; Carlo Heirman; Kris Thielemans; Karine Breckpot
Journal:  Oncotarget       Date:  2015-01-30

10.  Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasis.

Authors:  Sampath Katakam; Santosh Anand; Patricia Martin; Nicolo Riggi; Ivan Stamenkovic
Journal:  Life Sci Alliance       Date:  2022-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.